Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases

Mutation Research - Reviews in Mutation Research

Volumn 659, Issue 1-2, 2008, Pages 126-136

  Neri, Monica ^a   Ugolini, Donatella ^a,b   Dianzani, Irma ^c   Gemignani, Federica ^d   Landi, Stefano ^d   Cesario, Alfredo ^e,f   Magnani, Corrado ^c   Mutti, Luciano ^g   Puntoni, Riccardo ^a   Bonassi, Stefano ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^d UNIVERSITY OF PISA   (Italy)

^e CATHOLIC UNIVERSITY   (Italy)

^f IRCCS SAN RAFFAELE PISANA   (Italy)

^g Local Health Unit 11   (Italy)

Author keywords

Asbestos; DNA repair; Genetic polymorphism; Lung neoplasms; Mesothelioma; Oxidative stress

Indexed keywords

ALANINE; ALPHA 1 ANTITRYPSIN; ASBESTOS; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; MANGANESE SUPEROXIDE DISMUTASE; MYELOPEROXIDASE; REACTIVE OXYGEN METABOLITE; VALINE; XRCC1 PROTEIN; XRCC3 PROTEIN;

AEROBIC METABOLISM; ALLELE; ASBESTOSIS; CANCER RISK; CANCER SUSCEPTIBILITY; DNA REPAIR; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; LUNG CANCER; OXIDATIVE STRESS; PLEURA MESOTHELIOMA; PLEURA PLAQUE; PRIORITY JOURNAL; REVIEW; XENOBIOTIC METABOLISM;

ASBESTOS; DNA REPAIR; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; LUNG NEOPLASMS; MESOTHELIOMA; OXIDATIVE STRESS; PLEURAL NEOPLASMS; POLYMORPHISM, GENETIC;

EID: 47849091159     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrrev.2008.02.002     Document Type: Review

References (48)

1. Robinson B.W.S., Musk A.W., and Lake R.A. Malignant mesothelioma. Lancet 366 (2005) 397-408
2. Xu A., Zhou H., Yu D.Z., and Hei T.K. Mechanisms of the genotoxicity of crocidolite asbestos in mammalian cells: implication from mutation patterns induced by reactive oxygen species. Environ. Health Perspect. 110 (2002) 1003-1008
3. Kamp D.W., and Weitzman S.A. The molecular basis of asbestos induced lung injury. Thorax 54 (1999) 638-652
4. Schurkes C., Brock W., Abel J., and Unfried K. Induction of 8-hydroxydeoxyguanosine by man made vitreous fibers and crocidolite asbestos administered intraperitoneally in rats. Mutat. Res. 553 (2004) 59-65
5. Mossman B.T., Lounsbury K.M., and Reddy S.P. Oxidants and signaling by mitogen-activated protein kinases in lung epithelium. Am. J. Respir. Cell Mol. Biol. 34 6 (2006) 666-669
6. Manning C.B., Cummins A.B., Jung M.W., Berlanger I., Timblin C.R., Palmer C., Taatjes D.J., Hemenway D., Vacek P., and Mossman B.T. A mutant epidermal growth factor receptor targeted to lung epithelium inhibits asbestos-induced proliferation and proto-oncogene expression. Cancer Res. 62 (2002) 4169-4175
7. Li J., Poovey H.G., Rodriguez J.F., Brody A., and Hoyle G.W. Effect of platelet-derived growth factor on the development and persistence of asbestos-induced fibroproliferative lung disease. J. Environ. Pathol. Toxicol. Oncol. 23 (2004) 253-266
8. Subramanian J., and Govindan R.J. Lung cancer in never smokers: a review. Clin. Oncol. 25 (2007) 469-471
9. Cagle P.T., and Churg A. Differential diagnosis of benign and malignant mesothelial proliferations on pleural biopsies. Arch. Pathol. Lab. Med. 129 (2005) 1421-1427
10. Ascoli V., Cavone D., Merler E., Barbieri P.G., Romeo L., Nardi F., and Musti M. Mesothelioma in blood related subjects: report of 11 clusters among 1954 Italy cases and review of the literature. Am. J. Ind. Med. 50 (2007) 357-369
11. Ugolini D., Neri M., Ceppi M., Cesario A., Dianzani I., Filiberti R., Gemignani F., Landi S., Magnani C., Mutti L., Puntoni R., and Bonassi S. Genetic susceptibility to malignant mesothelioma and exposure to asbestos: the influence of the familial factor. Mutation Res. 658 (2008) 162-171
12. Smith C.M., Kelsey K.T., Wiencke J.K., Leyden K., Levin S., and Christiani D.C. Inherited glutathione-S-transferase deficiency is a risk factor for pulmonary asbestosis. Cancer Epidemiol. Biomark. Prev. 3 (1994) 471-477
13. Kelsey K.T., Nelson H.H., Wiencke J.K., Smith C.M., and Levin S. The glutathione S-transferase theta and mu deletion polymorphisms in asbestosis. Am. J. Ind. Med. 31 (1997) 274-279
14. Hirvonen A., Saarikoski S.T., Linnainmaa K., Koskinen K., Husgafvel-Pursiainen K., Mattson K., and Vainio H. Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders. J. Natl. Cancer Inst. 88 (1996) 1853-1856
15. Franko A., Dodič-Fikfak M., Arnerić N., and Dolžan V. Glutathione S-transferases GSTM1 and GSTT1 polymorphisms and asbestosis. J. Occup. Environ. Med. 49 (2007) 667-671
16. Horská A., Kazimírová A., Barancoková M., Wsólová L., Tulinská J., and Dusinská M. Genetic predisposition and health effect of occupational exposure to asbestos. NeuroEndocrinol. Lett. 2 Suppl. (2006) 100-103
17. Jakobsson K., Rannug A., Alexandrie A.K., Rylander L., Albin M., and Hagmar L. Genetic polymorphism for glutathione-S-transferase mu in asbestos cement workers. Occup. Environ. Med. 151 (1994) 812-816
18. Hirvonen A., Tuimala J., Ollikainen T., Linnainmaa K., and Kinnula V. Manganese superoxide dismutase genotypes and asbestos-associated pulmonary disorders. Cancer Lett. 178 (2002) 71-74
19. Zhao X.H., Jia G., Liu Y.Q., Liu S.W., Yan L., Jin Y., and Liu N. Association between polymorphisms of DNA repair gene XRCC1 and DNA damage in asbestos-exposed workers. Biomed. Environ. Sci. 19 (2006) 232-238
20. Lafuente M.J., Casterad X., Laso N., Mas S., Panades R., Calleja A., Hernandez S., Turuguet D., Ballesta A., Ascaso C., and Lafuente A. Pi*S and Pi*Z alpha 1 antitrypsin polymorphism and the risk for asbestosis in occupational exposure to asbestos. Toxicol. Lett. 136 (2002) 9-17
21. Afanaseva I.S., Spitsyn V.A., and Tsurikova G.V. The association of genetic and functional variability of alpha 1-antitrypsin in asbestosis. Genetika 29 (1993) 1727-1732
22. London S.J., Daly A.K., Cooper J., Navidi W.C., Carpenter C.L., and Idle J.R. Polymorphism of glutathione S-transferase M1 and lung cancer risk among African-Americans and Caucasians in Los Angeles County, California. J. Natl. Cancer Inst. 87 (1995) 1246-1253
23. Saarikoski S.T., Reinikainen M., Anttila S., Karjalainen A., Vainio H., Husgafvel-Pursiainen K., and Hirvonen A. Role of NAT2 deficiency in susceptibility to lung cancer among asbestos-exposed individuals. Pharmacogenetics 10 (2000) 183-185
24. Stucker I., Boffetta P., Antilla S., Benhamou S., Hirvonen A., London S., and Taioli E. Lack of interaction between asbestos exposure and glutathione S-transferase M1 and T1 genotypes in lung carcinogenesis. Cancer Epidemiol. Biomarkers Prev. 10 (2001) 1253-1258
25. Ozturk O., Isbir T., Yaylim I., Kocaturk C.I., and Gurses A. GST M1 and CYP1A1 gene polymorphism and daily fruit consumption in Turkish patients with non-small cell lung carcinomas. In Vivo 17 (2003) 625-632
26. London S.J., Daly A.K., Fairbrother K.S., Holmes C., Carpenter C.L., Navidi W.C., and Idle J.R. Lung cancer risk in African-Americans in relation to a race-specific CYP1A1 polymorphism. Cancer Res. 55 (1995) 6035-6037
27. Caporaso N., Hayes R.B., Dosemeci M., Hoover R., Ayesh R., Hetzel M., and Idle J. Lung cancer risk, occupational exposure, and the debrisoquine metabolic phenotype. Cancer Res. 49 (1989) 3675-3679
28. Schabath M.B., Spitz M.R., Delclos G.L., Gunn G.B., Whitehead L.W., and Wu X. Association between asbestos exposure, cigarette smoking, myeloperoxidase (MPO) genotypes, and lung cancer risk. Am. J. Ind. Med. 42 (2002) 29-37
29. Wang L.I., Neuberg D., and Christiani D.C. Asbestos exposure, manganese superoxide dismutase (MnSOD) genotype, and lung cancer risk. J. Occup. Environ. Med. 46 (2004) 556-564
30. Hirvonen A., Pelin K., Tammilehto L., Karjalainen A., Mattson K., Linnainmaa K., and Inherited GSTM1. NAT2 defects as concurrent risk modifiers in asbestos-related human malignant mesothelioma. Cancer Res. 55 (1995) 2981-2983
31. Neri M., Filiberti R., Taioli E., Garte S., Paracchini V., Bolognesi C., Canessa P.A., Fontana V., Ivaldi G.P., Verna A., Bonassi S., and Puntoni R. Pleural malignant mesothelioma, genetic susceptibility and asbestos exposure. Mutat. Res. 592 (2005) 36-44
32. Neri M., Taioli E., Filiberti R., Ivaldi G.P., Canessa P.A., Verna A., Marroni P., Puntoni R., Hirvonen A., and Garte S. Metabolic genotypes as modulators of asbestos-related pleural malignant mesothelioma risk: a comparison of Finnish and Italian populations. Int. J. Hyg. Environ. Health 209 (2006) 393-398
33. Dianzani I., Gibello L., Biava A., Giordano M., Bertolotti M., Betti M., Ferrante D., Guarrera S., Betta G.P., Mirabelli D., Matullo G., and Magnani C. Polymorphisms in DNA repair genes as risk factors for asbestos-related malignant mesothelioma in a general population study. Mutat. Res. 599 (2006) 124-134
34. Landi S., Gemignani F., Neri M., Barale R., Bonassi S., Bottari F., Canessa P.A., Canzian F., Ceppi M., Filiberti R., Ivaldi G.P., Mencoboni M., Scaruffi P., Tonini G.P., Mutti L., and Puntoni R. Polymorphisms of glutathione-S-transferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesothelioma. Int. J. Cancer 120 (2007) 2739-2743
35. Mapp C.E. Occupational lung disorders. Eur. Respir. Mon. 11 (1999) 170
36. Gennaro V., Ugolini D., Viarengo P., Benfatto L., Bianchelli M., Lazzarotto A., Montanaro F., and Puntoni R. Incidence of pleural mesothelioma in Liguria Region, Italy (1996-2002). Eur. J. Cancer 41 (2005) 2709-2714
37. Magnani C., Agudo A., Gonzalez C.A., Andrion A., Calleja A., Chellini E., Dalmasso P., Escolar A., Hernandez S., Ivaldi C., Mirabelli D., Ramirez J., Turuguet D., Usel M., and Terracini B. Multicentric study on malignant pleural mesothelioma and nonoccupational exposure to asbestos. Br. J. Cancer 83 (2000) 104-111
38. Magnani C., Dalmasso P., Biggeri A., Ivaldi C., Mirabelli D., and Terracini B. Increased risk of malignant mesothelioma of the pleura after residential or domestic exposure to asbestos. A case-control study in Casale Monferrato-Italy. Environ. Health Perspect. 109 (2001) 915-919
39. Magnani C., Ferrante D., Barone-Adesi F., Bertolotti M., Todesco A., Mirabelli D., and Terracini B. Cancer risk after cessation of asbestos exposure. A cohort study of Italian asbestos cement workers. Occup. Environ. Med. 65 (2008) 164-170
40. Kinnula V.L., Pietarinen-Runtti P., Raivio K., Kahlos K., Pelin K., Mattson K., and Linnainmaa K. Manganese superoxide dismutase in human pleural mesothelioma cell lines. Free Radic. Biol. Med. 21 (1996) 527-532
41. Kahlos K., Anttila S., Asikainen T., Kinnula K., Raivio K.O., Mattson K., Linnainmaa K., and Kinnula V.L. Manganese superoxide dismutase in healthy human pleural mesothelium and in malignant pleural mesothelioma. Am. J. Respir. Cell Mol. Biol. 18 (1998) 570-580
42. Landi S., Gemignani F., Monnier S., and Canzian F. A database of single-nucleotide polymorphisms and a genotyping microarray for genetic epidemiology of lung cancer. Exp. Lung Res. 31 (2005) 223-258
43. Rothman K.J. No adjustments are needed for multiple comparisons. Epidemiology 1 (1990) 43-46
44. Wacholder S., Chanock S., Garcia-Closas M., El ghormli L., and Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J. Natl. Cancer Inst. 96 (2004) 434-442
45. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B., Higgins J., DeFelice M., Lochner A., Faggart M., Liu-Cordero S.N., Rotimi C., Adeyemo A., Cooper R., Ward R., Lander E.S., Daly M.J., and Altshuler D. The structure of haplotype blocks in the human genome. Science 296 (2002) 2225-2229
46. Pharoah P.D., Dunning A.M., Ponder B.A., and Easton D.F. Association studies for finding cancer-susceptibility genetic variants. Nat. Rev. Cancer 4 (2004) 850-860
47. Gibbs R.A., Belmont J.W., Hardenbol P., Willis T.D., Yu F., Yang H., et al. The International HapMap Consortium. The International HapMap Project. Nature 426 (2003) 789-796
48. Raimondi S., Paracchini V., Autrup H., Barros-Dios J.M., Benhamou S., Boffetta P., Cote M.L., Dialyna I.A., Dolzan V., Filiberti R., Garte S., Hirvonen A., Husgafvel-Pursiainen K., Imyanitov E.N., Kalina I., Kang D., Kiyohara C., Kohno T., Kremers P., Lan Q., London S., Povey A.C., Rannug A., Reszka E., Risch A., Romkes M., Schneider J., Seow A., Shields P.G., Sobti R.C., Sørensen M., Spinola M., Spitz M.R., Strange R.C., Stücker I., Sugimura H., To-Figueras J., Tokudome S., Yang P., Yuan J.M., Warholm M., and Taioli E. Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am. J. Epidemiol. 164 (2006) 1027-1042